AP
LLY icon

Archon Partners’s Eli Lilly LLY Stock Holding History

Archon Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4M Buy
12,000
+3,000
+33% +$3.07M 1.54% 24
2026
Q1 		$8.28M Hold
9,000
– – 0.98% 32
2025
Q4 		$9.67M Hold
9,000
– – 1.01% 31
2025
Q3 		$6.87M Buy
+9,000
New +$6.7M 0.73% 34

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Archon Partners's LLY Position: Q2 2026 in Review

Archon Partners increased its Eli Lilly (LLY) stake by 33% in Q2 2026, buying an estimated $3.07M and bringing the position to 12,000 shares worth $14.4M. The position accounts for 1.54% of the portfolio, ranked #24.

Archon Partners first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. 3,576 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Archon Partners held 12,000 shares of Eli Lilly worth $14.4M as of Q2 2026.
  • Archon Partners bought 3,000 Eli Lilly shares in Q2 2026, an estimated $3.07M.
  • Eli Lilly made up 1.54% of Archon Partners's portfolio in Q2 2026, its #24 holding.
  • Archon Partners first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • 3,576 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Archon Partners's 13F filing for Q2 2026, filed 6 Aug 2026.